Is Oak Longevity legit?

Who actually operates it

United States

What third-party reviewers say

Oak Longevity has a strongly positive but small third-party footprint: a Trustpilot TrustScore around 4.5 across roughly 46 reviews, praising fast/easy onboarding, quick delivery, competitive semaglutide pricing and responsive human customer service. The most recurring criticism is that it does not offer anti-nausea medication despite nausea being a common GLP-1 side effect.

Reddit sentiment (positive): No Oak-specific Reddit threads surfaced in search; third-party discussion is concentrated on Trustpilot rather than Reddit.

Trustpilot verified June 19, 2026, external-reviews verification pass..

What people complain about with Oak Longevity

• •Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct
• •No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
• •The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan
• •The longevity add-ons (NAD+, Sermorelin, Tesamorelin) have limited clinical evidence for weight loss specifically, if weight loss is the goal, the GLP-1 alone does the work and the stack is optional
• •Newer brand without disclosed company history, founding date, or executive team on landing pages
• •Three-month plans are billed upfront, start on the 1-month plan if you're testing the platform, then bundle once it fits

Our verdict

Oak Longevity competes on price and billing freedom. $130/mo compounded semaglutide and $199/mo tirzepatide sit at the lower end of the market, the manual-renewal model means you're never auto-charged, and the broad menu (including a $100 oral Wegovy 4-week supply) gives users options most platforms don't offer. Buy it right: stick to the compounded tiers, brand-name at $1,200-$1,500/mo is far above NovoCare and LillyDirect direct pricing, and treat the longevity add-ons (NAD+, Sermorelin, Tesamorelin) as optional, their weight-loss evidence is limited. Patients with comorbidities who need labs and structured oversight fit better on a clinically deeper platform. For healthy budget-conscious users, Oak is one of the strongest value entries we track: start with the $133 semaglutide month, code OAKNEW50 brings month one to $83.